|
|
|
|
|
Cribriform morular variant of papillary thyroid carcinoma: Clinical and cytomorphological features on fine-needle aspiration |
2556 |
# |
|
|
|
|
|
Creation of an integrated outcome database for pediatric anesthesia |
2559 |
# |
|
|
|
|
|
Cranial dural arteriovenous shunts: An evaluation of the outcome |
2561 |
# |
|
|
|
|
|
Cranial dural arteriovenous fistulas: Can noninvasive imaging predict angiographic findings? |
2561 |
# |
|
|
|
|
|
COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics |
2563 |
# |
|
|
|
|
|
COVID-19-associated myositis may be dermatomyositis |
2564 |
# |
|
|
|
|
|
COVID-19 vaccine boosters in the Asia-Pacific region in the context of Omicron |
2565 |
# |
|
|
|
|
|
COVID-19 Pandemic and Burden of Non-Communicable Diseases: An Ecological Study on Data of 185 Countries |
2563 |
# |
|
|
|
|
|
COVID-19 in dermatology practice: getting back on track |
2563 |
# |
|
|
|
|
|
COVID-19 Breakthrough Infection after Inactivated Vaccine Induced Robust Antibody Responses and Cross-Neutralization of SARS-CoV-2 Variants, but Less Immunity against Omicron |
2565 |
# |
|
|
|
|
|
COVID-19 and older people in Asia: Asian Working Group for Sarcopenia calls to actions |
2563 |
# |
|
|
|
|
|
COVID-19 and gynecological cancers: Asia and Oceania Federation of Obstetrics and Gynecology oncology committee opinion |
2564 |
# |
|
|
|
|
|
Covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope |
2560 |
# |
|
|
|
|
|
Country Level Diversity of the HIV-1 Pandemic between 1990 and 2015 |
2564 |
# |
|
|
|
|
|
Cotrimoxazole prophylaxis decreases tuberculosis risk among Asian patients with HIV |
2562 |
# |
|
|
|
|
|
Cost–Utility Analysis of Dapagliflozin as an Add-on to Standard of Care for Patients with Chronic Kidney Disease in Thailand |
2565 |
# |
|
|
|
|
|
Cost-utility and budget impact analysis of tocilizumab for the treatment of refractory systemic juvenile idiopathic arthritis in Thailand |
2563 |
# |
|
|
|
|
|
Cost-Utility Analysis of Vasoconstrictors Plus Albumin in the Treatment of Thai Patients with Type 1 Hepatorenal Syndrome |
2564 |
# |
|
|
|
|
|
Cost-Utility Analysis of Transcatheter Aortic Valve Implantation versus Surgery in High-Risk Severe Aortic Stenosis Patients in Thailand |
2565 |
# |
|
|
|
|
|
Cost-Utility Analysis of Sacubitril-Valsartan Compared with Enalapril Treatment in Patients with Acute Decompensated Heart Failure in Thailand |
2564 |
# |
|
|
|
|
|
COST-UTILITY ANALYSIS OF PREEMPTIVE LIVING-RELATED KIDNEY TRANSPLANTATION COMPARE TO NONPREEMPTIVE STRATEGIES IN THAILAND |
2564 |
# |
|
|
|
|
|
COST-UTILITY ANALYSIS OF MULTIPLE SCLEROSIS TREATMENT IN THAILAND. |
2561 |
# |
|
|
|
|
|
COST-UTILITY ANALYSIS OF HERPES ZOSTER VACCINE IN THAILAND |
2560 |
# |
|
|
|
|
|
Cost-Utility Analysis of Erythropoietin for Anemia Treatment in Thai End-Stage Renal Disease Patients with Hemodialysis |
2557 |
# |
|
|
|
|
|
Cost-Utility Analysis of Dapagliflozin as an Add-On to Standard Treatment for Patients with Type 2 Diabetes and High Risk of Cardiovascular Disease in Thailand |
2564 |
# |
|
|
|
|
|
Cost-Utility Analysis of Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis for Thai End-Stage Renal Disease Patients |
2563 |
# |
|
|
|
|
|
Cost-Utility Analysis of Combination Empagliflozin and Standard Treatment Versus Standard Treatment Alone in Thai Heart Failure Patients with Reduced or Preserved Ejection Fraction |
2565 |
# |
|
|
|
|
|
Cost-utility analysis of adjuvant chemotherapy in patients with stage III colon cancer in Thailand. |
2558 |
# |
|
|
|
|
|
Cost-utility analysis of add-on dapagliflozin treatment in heart failure with reduced ejection fraction |
2564 |
# |
|
|
|
|
|
Cost-Utility Analysis Compared Between Radiotherapy Alone and Combined Surgery and Radiotherapy for Symptomatic Spinal Metastases in Thailand |
2565 |
# |